Table of Contents
Contracts & Grants
Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.
New
Jeffrey K. Actor, Medical School (MS) and Graduate School of Biomedical Sciences (GSBS), Regulation of Cortisol by Mycobacterial Glycolipid TDM, National Institutes of Health (NIH), National Heart, Lung and Blood Institute (NHLBI), $363,878.
Rajesh Balkrishnan, School of Public Health (SPH) and GSBS, Classification of Care for Breast Cancer under Medicaid,Wake Forest University, $17,298.
Ben J. Barnett, MS, A Phase II Open-Label, Randomized, Active-Controlled Study Comparing the Efficacy and Safety of Once Daily Enfuvirtide Dosing Versus the Currently Recommended Twice Daily Dosing in HIV-1 Infected Treatment-Experienced Patients, Hoffmann Laroche Inc., $52,231.
Deborah L. Brown, MS, Exploratory, Multi-Centre, Ramdomized, Double-Blind, Uncontrolled Trial Evaluating the Efficacy of Activated Recombinant Factor VII (Rfviianovoseven) in Secondary Bleeding Prophylaxis in Congenital Haemophilia A or B Patients with Inhibitors, Novo Nordisk Pharmaceuticals Inc., $73,725.
Jeffrey C. Chang, Dental Branch (DB), Microleakage of Human Teeth with Three Dentin Bonding Agents, Parkell, $3,589.
Cynthia L. Chappell, SPH, Optimizing Detection Methods for Trypanosoma Cruzi Texas Isolates, The University of Texas Medical Branch at Galveston, $12,657.
John Y. Choi, MS, Telemedicine Feasibility Study of IV Nicardipine in Blood Pressure Management of Acute Ischemic Stroke, Excellence in Specialty Pharmaceuticals, $29,250; and Telemedicine Feasibility Study of IV Nicardipine in Blood Pressure Management of Acute Hemorrhagic Stroke, Excellence in Specialty Pharmaceuticals, $31,200.
Giuseppe N. Colasurdo, MS, SP-A Signalling and Age-Dependent Vulnerability to PM, NIH, National Institute of Environmental Health Sciences, $408,375.
Pamela M. Diamond, SPH, Traumatic Brain Injury in Federal Prison Inmates, Centers for Disease Control and Prevention (CDC), $184,439.
Valentin Dragoi, MS and GSBS, Network Mechanisms of Visual Behavior, Pew Scholars Program, $240,000.
Rebecca G. Girardet, MS, Comparison of the Urine-Based Ligase Chain Reaction Test to Culture for Detection of Chlamydia Trachomatis, CDC, $15,000.
Adelaide A. Hebert, MS, Safety Study of Topical Corticosteroid Cream in Pediatric Subjects Aged 3 Years to 5 Years 11 Months with Atopic Dermatitis, Bailer Research Inc., $51,658; A Safety Study of Topical Corticosteroid Cream in Pediatric Subjects Aged 3 Months to 35 Months with Atopic Dermatitis, Bailer Research Inc., $51,658; and A Randomized, Evaluation-Blind, Three-Arm, Multi- Center Study to Evaluate the Safety and Efficacy of Topically Applied Desonide Gel 0.05% Vs, Desonide Gel Vehicle and Desowen (R) Lotion for the Treatment of Pediatric Subject with Mild to Moderate Atopic Dermatitis, SFBC International, $36,530.
Keith Hoots, MS, Obesity in Hemophilia: Prevalence and Risk Factors, National Hemophilia Foundation, $10,000; National Hemophilia Foundation Clinical Fellowship Program, National Hemophilia Foundation, $183,144; and The Feiba-Novoseven Comparative (FENOC) Study, Malmo University Hospital, $3,120.
Sheila Koh, DB, Clinical Evaluation of the Bleaching Efficacy of Two Different Methods, Premier Dental Products, $11,999.
Hualou Liang, School of Health Information Sciences (SHIS) and GSBS, Effects of Attention on Neural Ensembles in Visual Cortex, Whitehall Foundation Inc., $75,000.
Scott R. Lillibridge, SPH, Texas Statewide Bioterrorism Continuing Education Program - Two Hour Nursing CE, Texas Department of Health, $103,606; and CDC: Centers For Public Health Preparedness, CDC, $5,630,395.
Robert F. Lodato, MS, A Phase 3, Multicenter, Randomized, Placebo-Comtrolled, Double-Blind, Three-Arm Study to Evaluate the Safety and Efficacy of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) Administration in Subjects with Severe Community-Acquired Pneumonia, Chiron Corporation, $71,600.
Yahaun Lou, DB and GSBS, Minimal Change Disease: A Disorder of Cell Mediated Immunity, Baylor College of Medicine, $13,270.
Olasupo A. Olagundoye, MS, Is Obesity a Barrier to Pap Smear and Mammography Screening, Texas Academy of Family Physicians Foundation, $5,000.
John M. Powers, DB and GSBS, Bond Strength of Experimental Nano-Bond 2, Pentron Clinical Technologies, LLC, $1,600;Wear of New Resin Composites, Tokuyama Dental Corp., $2,400; Bond Strength of Pit and Fissue Sealants in Contaminated Environments, Dentsply International, $2,500; Properties of Exaimplant, GC America Inc., $5,000; Bond Strength of Adhesive Systems to Tooth Structure as Affected by Moisture, GC America Inc., $15,000; and Retention of Cemented Vs Bonded Crowns, Heraeus Kulzer Inc., $4,800.
Marek W. Radomski, MS, Mechanisms of Pharmacological Action of P58: Focus on Platelet-Induced Angiogenesis, Phytopharm, $44,200.
Martha S. Vela-Acosta, SPH, HICAHS - Improved Methods of Obtaining Injury Information from Migrant Farmworkers, Colorado State University, $7,912.
Sally W. Vernon, SPH, Colorectal Cancer Screening Assessment and Surveillance Data System, Veterans Administration Medical Center, $73,868.
Audrey Wanger, MS and GSBS, Assessment of In-Vitro Synergy in Clincal Isolates of Multi-Drug Resistant Acinetobacter, Elan Pharmaceuticals, $26,260.
Willy R. Wriggers, SHIS and GSBS, Keck Fellowships - Stefan Birmanns, Baylor College of Medicine, $20,000.
Renewal
Eric Boerwinkle, SPH, GSBS and Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), Molecular Epidemiology of Essential Hypertension, NIH, NHLBI, $6,637,290.
Stephen P. Daiger, SPH and GSBS, Molecular Studies of Autosomal Forms of Retinitis Pigmentosa, Foundation for Fighting Blindness, $280,035.
Robert J. Hardy, SPH, Early Treatment for Retinopathy of Prematurity (ETROP) - Coordinating Center, NIH, National Eye Institute, $7,911,013.
Rodney C. Lester, School of Nursing, Nurse Anesthetist Traineeship, Health Resources and Services Administration, $50,039.
Carlos A. Moreno, MS and Health Science Center Administration, Academic Administrative Units in Primary Care, Health Resources and Services Administration, $349,118.
Susan R. Tortolero, SPH, Health Promotion and Disease Prevention Research Centers, CDC, $5,494,449.
Jiajie Zhang, SHIS, Human Centered Intelligent Flight Surgeon Console-Evaluation, Refinement and Deployment, National Aeronautics and Space Administration, Ames, $109,340.
Transfer
Cheng C. Lee, MS and GSBS, Mammalian Circadian Clock Defects and Premature Aging, NIH, National Institute on Aging, $1,334,002.

